Skin, immunity & wound research
LL-37 research.
A closer look at immune and repair claims.
The science behind the body’s defenses is fascinating. Explore where LL-37 has been studied, where the findings stop, and how to start a useful discussion about your skin or wellness concerns.
Educational research topic · No LL-37 treatment is offered on this page.
Questions worth exploring
Clear prices. A clearer next step.
Explore the research. Understand the price context.
The research-market figure below is educational context. Neither a free account nor optional membership purchases access to this compound.
Estimated research-market price · not a treatment offer
LL-37 · research market context
Est. $89per 5 mg laboratory research vial
Single selected public supplier listing. This is research-market context, not a clinical drug quote, treatment cost or purchase offer.
Research-material market context only. Seine Bio does not sell lyophilized powders for self-reconstitution or offer this research compound. This figure does not price a finished clinical product; any lawful treatment requires its own quote. Membership does not provide the named investigational compound.
Discuss my care optionsPrice sources & what is included
Public research-material listings reviewed October 7, 2026. Prices and stock can change; taxes and shipping may be additional. These source links document laboratory listings, not patient-use products, supplier quality or lawful clinical availability.
Optional product-savings membership
Start with a personal care conversation.
$20Per month · Cancel anytime
- 2% off products; therapy services and membership dues excluded
- Free two-business-day shipping after dispatch on $100+ physical-product orders before discounts and taxes in the contiguous United States
- Cancel anytime to stop future membership renewals
Medication, labs, products and additional treatment cost extra. Care is subject to clinical fit and availability. Membership does not guarantee a prescription, named peptide or research enrollment.
Create a free account ↗Understand the topic
LL-37.
A clearer overview.
Start with the research. Keep your goals in view.
Research topic. LL-37 is not an FDA-approved general immune, infection or wound-healing therapy. This page does not offer LL-37 treatment.
What makes it interesting.
LL-37 is a human cathelicidin peptide involved in innate immune biology. Experiments examine antimicrobial activity, inflammatory signaling and tissue-repair processes. An endogenous peptide’s biological role does not establish that adding a manufactured version is beneficial or safe.
The story behind the interest.
LL-37 attracted clinical interest because of its role in barrier tissues and immune responses. Human trials have investigated specific topical wound preparations. This is a more focused research history than the broad online claims about systemic immune enhancement or treating persistent infections.
Evidence before expectations
Read beyond
the headline.
A useful research discussion includes the study design, the population and the outcome measured.
Read the original sourcesA 2021 phase IIb study enrolled 148 patients with difficult-to-heal venous leg ulcers. Topical LL-37 was used alongside compression therapy. The full study population did not show a significant improvement over placebo; a post hoc large-wound subgroup finding required further study.
A separate 2023 randomized trial studied LL-37 cream in diabetic foot ulcers and reported improved healing measures, without the expected reduction in the measured inflammatory markers or bacterial colonization. That result is specific to a topical product and wound population.
These studies do not validate injectable LL-37 for chronic infections, general immune support or wellness. For a wound or infection concern, identifying the cause and arranging appropriate clinical care are more useful than applying broad claims from another research setting.
| Research setting | What the record shows | What it does not establish |
|---|---|---|
| Venous leg-ulcer trial | A 148-patient study found no significant full-cohort healing benefit. | A subgroup observation is not a confirmed general benefit. |
| Diabetic foot-ulcer trial | A topical cream study reported improved healing measures. | Does not validate systemic injection or infection treatment. |
| Immune biology | LL-37 participates in innate immune signaling. | Natural occurrence does not establish treatment safety. |
Understand the evidence
Understanding doses
and cycles.
A clear reference for your conversation with a clinician.
Research doses describe a specific study, not a treatment plan. Online popularity does not establish safety.
| Preparation / context | Dose reference | Frequency | Duration / cycle | Evidence & source |
|---|---|---|---|---|
| LL-37 | Not established for this proposed wellness use | Not established | No validated human on/off cycle | Evidence limitations A generic immune or infection-treatment cycle is not established. Read the source |
Swipe or scroll sideways to see every column. There is no universal peptide cycle. A published trial, a product label and an informal online protocol are different kinds of information.
Sources reviewed October 7, 2026. A dose listed here does not establish availability or suitability through Seine Bio.
Discuss my optionsAn honest view of uncertainty
Ask better questions.
Understand the concerns.
Missing safety information cannot be treated as proof that a product is safe.
Risks & concerns
What deserves attention.
- FDA cites limited safety data and nonclinical reproductive and tumor-related concerns.
- Immune activity is context dependent; more activity does not automatically mean a better clinical outcome.
- Wounds, fever or infection symptoms need appropriate evaluation. Research compounds should not replace prescribed infection or wound care.
A compound’s name, a purity claim or research-use labeling does not establish patient-ready quality, sterility or a reliable clinical outcome.
Regulatory context
Review is not an approval.
LL-37 appears in FDA’s current withdrawn-nomination safety table. It was not on the July 2026 seven-substance agenda. A nomination change does not constitute an approved treatment.
Compounding review, permission to conduct research and approval of a finished drug are different decisions. This page is an invitation to learn and discuss appropriate care, not a statement that this compound can be supplied.
Check the official sourcesThe goal behind your search
Bring the question.
Keep your care grounded.
If LL-37 caught your attention, tell us what you hoped it might address. We can explain the next care conversation and appropriate referral options. A clinician may discuss established treatment, further assessment or relevant research information; no experimental-product access is promised.
Share your goal.
Create a free account. Tell the team which care conversation interests you; keep sensitive health details for private clinical intake.
Understand your options.
The appropriate clinician can discuss the research, its limitations and established alternatives. Relevant research resources may be discussed when appropriate; eligibility and access are controlled by the study or sponsor.
Choose your next step.
Review suitability, available care and clear costs before deciding. A plan may involve established treatment, a referral or further assessment. No particular prescription or research access is guaranteed.
Good questions welcome
Make the next
step clearer.
You can be curious about research and still choose a practical care path available today.
Is LL-37 an antibiotic?
LL-37 has antimicrobial activity in experimental research, but this does not make an unapproved preparation an established antibiotic or a substitute for appropriate infection treatment.
Do the wound studies support an injection?
No. The cited human trials studied topical preparations in particular wound populations. Their findings cannot establish the safety or effectiveness of systemic injection.
Does the venous-ulcer trial prove it works?
The main analysis did not show significant healing improvement across the whole study population. The favorable large-wound subgroup analysis was exploratory and needed a further adequately designed study.
Can Seine Bio help me understand the research?
Yes. Start an inquiry about your goals. The team can explain the appropriate clinical discussion and available care options. Active infection or worsening wounds should be assessed promptly by an appropriate clinician.
A simple place to start
Bring your questions.
Explore your next step.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
- A free account with basic contact details
- Screening and clear costs before payment
- Established alternatives discussed when appropriate
An inquiry is not an application for guaranteed access to this compound. Membership does not include or guarantee experimental treatment. Any clinical care and costs will be explained separately.
Start with a free account.
Optional membership: $20/month.
Optional · $20/month · Cancel anytime. Medications, labs, products, additional therapy and separately priced treatments cost extra.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
Please keep medical history, medications and sensitive personal details for private clinical intake.
Learn more
Read the sources.
Bring your questions.
Original research and official regulatory materials help put claims into context. Study links are educational and do not establish a treatment offer.
Reviewed October 7, 2026. Regulatory status and research records may change.
Questions about LL-37?Start a care conversation
Start my inquiryClinical inquiries: age 18+. Research information does not imply treatment availability. Clinical decisions require an individual evaluation by an appropriate licensed clinician. An inquiry or membership does not guarantee a prescription, research enrollment or a specific outcome.
We do not provide emergency services. For immediate danger or a medical emergency, call 911. For a mental health crisis in the U.S., call or text 988.